99 related articles for article (PubMed ID: 31037745)
1. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
Yu H; Shi Z; Wu Y; Wang CH; Lin X; Perschon C; Isaacs WB; Helfand BT; Lilly Zheng S; Duggan D; Mo Z; Lu D; Xu J
Prostate; 2019 Jul; 79(10):1099-1105. PubMed ID: 31037745
[TBL] [Abstract][Full Text] [Related]
2. Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment.
Yu H; Shi Z; Lin X; Bao Q; Jia H; Wei J; Helfand BT; Zheng SL; Duggan D; Lu D; Mo Z; Xu J
Prostate; 2020 Jan; 80(1):83-87. PubMed ID: 31634418
[TBL] [Abstract][Full Text] [Related]
3. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract][Full Text] [Related]
4. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R
Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471
[TBL] [Abstract][Full Text] [Related]
6. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
[TBL] [Abstract][Full Text] [Related]
7. Clinical validity and utility of genetic risk scores in prostate cancer.
Helfand BT; Kearns J; Conran C; Xu J
Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
[TBL] [Abstract][Full Text] [Related]
8. Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.
Wei J; Shi Z; Na R; Resurreccion WK; Wang CH; Duggan D; Zheng SL; Hulick PJ; Helfand BT; Xu J
J Med Genet; 2022 Mar; 59(3):243-247. PubMed ID: 33443076
[TBL] [Abstract][Full Text] [Related]
9. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
[TBL] [Abstract][Full Text] [Related]
10. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.
Na R; Ye D; Qi J; Liu F; Lin X; Helfand BT; Brendler CB; Conran C; Gong J; Wu Y; Gao X; Chen Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J
Asian J Androl; 2016; 18(4):525-9. PubMed ID: 27140652
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors influencing prostate cancer risk in Norwegian men.
Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
[TBL] [Abstract][Full Text] [Related]
12. A comparison of genetic risk score with family history for estimating prostate cancer risk.
Helfand BT
Asian J Androl; 2016; 18(4):515-9. PubMed ID: 27004541
[TBL] [Abstract][Full Text] [Related]
13. Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.
Shi Z; Zhan J; Wei J; Ladson-Gary S; Wang CH; Hulick PJ; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; ; Koelsch BL; Xu J
Eur Urol Open Sci; 2022 Nov; 45():23-30. PubMed ID: 36353656
[TBL] [Abstract][Full Text] [Related]
14. Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Xu J; Isaacs WB; Mamawala M; Shi Z; Landis P; Petkewicz J; Wei J; Wang CH; Resurreccion WK; Na R; Bhanji Y; Novakovic K; Walsh PC; Zheng SL; Helfand BT; Pavlovich CP
Prostate; 2021 Jul; 81(10):703-709. PubMed ID: 33956350
[TBL] [Abstract][Full Text] [Related]
15. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
[TBL] [Abstract][Full Text] [Related]
16. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
[TBL] [Abstract][Full Text] [Related]
17. Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.
Zhang GM; Zhu Y; Chen HT; Han CT; Liu F; Xu JF; Ye DW
Medicine (Baltimore); 2015 Oct; 94(42):e1603. PubMed ID: 26496266
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.
Weijmans M; de Bakker PI; van der Graaf Y; Asselbergs FW; Algra A; Jan de Borst G; Spiering W; Visseren FL;
Atherosclerosis; 2015 Apr; 239(2):451-8. PubMed ID: 25687271
[TBL] [Abstract][Full Text] [Related]
19. Multigene panels in prostate cancer risk assessment.
Little J; Wilson B; Carter R; Walker K; Santaguida P; Tomiak E; Beyene J; Raina P
Evid Rep Technol Assess (Full Rep); 2012 Jul; (209):1-166. PubMed ID: 24423032
[TBL] [Abstract][Full Text] [Related]
20. Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Shi Z; Yu H; Wu Y; Lin X; Bao Q; Jia H; Perschon C; Duggan D; Helfand BT; Zheng SL; Xu J
Cancer Med; 2019 Jun; 8(6):3196-3205. PubMed ID: 30968590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
